Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Futura Medical, a manufacturer of consumer healthcare products, has added a new treatment for cellulite to its product development pipeline.
Subscribe to our email newsletter
The Cellulite Reduction Formula by Futura, codenamed CRF100, is an alkaloid containing topically applied cream that comprises DermaSys delivery system.
CRF100 has demonstrated an eight-fold improvement in delivery of the alkaloid through the skin compared with other comparator products, in in vitro trials.
According to the company, DermaSys, that provides improved permeation, leads to a physiologically active dose of the alkaloid in the subcutaneous tissues.
Futura Medical said that CRF100 will be an over-the-counter product and will be licensed at an appropriate time to a major global company for commercialisation.